Journal of medicinal and pharmaceutical chemistry 2010-11-11

Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.

H Dalton King, Zhaoxing Meng, Jeffrey A Deskus, Charles P Sloan, Qi Gao, Brett R Beno, Edward S Kozlowski, Melissa A Lapaglia, Gail K Mattson, Thaddeus F Molski, Matthew T Taber, Nicholas J Lodge, Ronald J Mattson, John E Macor

Index: J. Med. Chem. 53 , 7564, (2010)

Full Text: HTML

Abstract

A series of conformationally restricted homotryptamines has been synthesized and shown to be potent inhibitors of hSERT. Conformational restriction of the homotryptamine side chain was attained by the insertion of a cyclopentyl ring, with the indole ring and the terminal dialkylamino group occupying the 1- and 3-positions, respectively. Nitrile and fluoro substitutions at the indole 5-position gave highest hSERT potency. Preferred cyclopentane ring stereochemistry in both series was cis (1S,3R for 5-CN compound 8a, 1R,3S for 5-F compound 9a). High hSERT binding affinity was observed for 8a and 9a (0.22 and 0.63 nM, respectively). The corresponding trans isomers were 4-9 times less potent. 8a, dosed at 1 and 3 mg/kg po, produced a robust, dose-dependent increase in extracellular serotonin in the frontal cortex of rats, similar to that induced by paroxetine at 5 mg/kg, po. By contrast, 9a did not produce a significant increase in extracellular serotonin in rat frontal cortex at 3 mg/kg po due to relatively low brain and plasma levels.


Related Compounds

Related Articles:

Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.

2011-08-11

[J. Med. Chem. 54 , 5320, (2011)]

Ionization potentials of fluoroindoles and the origin of nonexponential tryptophan fluorescence decay in proteins.

2005-03-23

[J. Am. Chem. Soc. 127(11) , 4104-13, (2005)]

Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.

2011-01-13

[J. Med. Chem. 54 , 166, (2011)]

Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.

2011-05-15

[Bioorg. Med. Chem. 19 , 3204, (2011)]

3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.

1994-06-24

[J. Med. Chem. 37 , 2011, (1994)]

More Articles...